Translumina Therapeutics, India's largest domestic player in the coronary stents market, announces the initiation of direct operations in the UAE

New Delhi [India], September 21: Translumina was incorporated in 2011 as a sales & marketing company specialising in coronary intervention devices. Since its inception, the company has successfully established their own manufacturing capabilities and developed in-house product lines, which are endorsed by interventional cardiologists worldwide.